Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News

    Latest News - Page 28

    Torrent Pharma Q3 net profit up 2 pc at Rs 251 crore

    Torrent Pharma Q3 net profit up 2 pc at Rs 251 crore

    MD bureau28 Jan 2020 2:25 PM IST
    New Delhi: Drug firm Torrent Pharmaceuticals on Monday reported a 2.03 percent rise in its consolidated net profit to Rs 251 crore for the quarter...
    USFDA issues Form 483 with 5 observations to Biocon Bengaluru facility

    USFDA issues Form 483 with 5 observations to Biocon Bengaluru facility

    MD bureau28 Jan 2020 2:24 PM IST
    New Delhi: Biocon Ltd on Monday said the US health regulator conducted a pre-approval inspection and good manufacturing practice (GMP) examination of...
    NY, feds sue Pharma Bro Martin Shkreli for scheme to keep drug price up

    NY, feds sue 'Pharma Bro' Martin Shkreli for 'scheme' to keep drug price up

    MD bureau28 Jan 2020 2:21 PM IST
    NEW YORK - State and federal authorities sued imprisoned entrepreneur Martin Shkreli on Monday over tactics that shielded a profitable drug from...
    Lupin Pithampur facilities complete successful MHRA inspection

    Lupin Pithampur facilities complete successful MHRA inspection

    MD bureau28 Jan 2020 2:06 PM IST
    New Delhi: Pharma major Lupin on Monday said the UK Medicines and Healthcare products Regulatory Agency (MHRA), the regulatory agency of the United...
    Ervaxx, Cardiff University enter collaboration to develop novel 
T-cell and T-cell receptor-based immunotherapeutics targeting 
Dark Antigens™

    Ervaxx, Cardiff University enter collaboration to develop novel 
T-cell and T-cell receptor-based immunotherapeutics targeting 
Dark Antigens™

    Medical Dialogues Bureau27 Jan 2020 2:31 PM IST
    London: Ervaxx™, a biotechnology company pioneering the use of Dark Antigens™ to develop T-cell receptor (TCR)-based immunotherapies and off-the-shelf...
    Bayer appoints Bijoy Sagar as new Chief Information Technology & Digital Transformation Officer

    Bayer appoints Bijoy Sagar as new Chief Information Technology & Digital Transformation Officer

    MD bureau27 Jan 2020 2:29 PM IST
    Leverkusen: Bijoy Sagar (50) will be Bayer's new Chief Information Technology & Digital Transformation Officer (CIDO) effective June 1,...
    Roche provides update on Phase III study of Tecentriq in people with muscle-invasive urothelial cancer

    Roche provides update on Phase III study of Tecentriq in people with muscle-invasive urothelial cancer

    MD bureau27 Jan 2020 2:22 PM IST
    Basel: Roche has announced that the Phase III IMvigor010 study evaluating Tecentriq® (atezolizumab) as an adjuvant (after surgery) monotherapy...
    USFDA completes inspection of Strides Pharmas Alathur facility with zero observations

    USFDA completes inspection of Strides Pharma's Alathur facility with zero observations

    MD bureau26 Jan 2020 2:00 PM IST
    New Delhi: Drug firm Strides Pharma Science on Friday said the US health regulator has completed inspection of its Alathur facility in Tamil Nadu with...
    Roche wins approval for cancer drug Kadcyla in China

    Roche wins approval for cancer drug Kadcyla in China

    Medical Dialogues Bureau26 Jan 2020 10:15 AM IST
    Beijing/Zurich: Roche said on Wednesday China had approved the import of its Kadcyla drug for breast cancer, another win for the Swiss drugmaker in...
    Kiran Mazumdar Shaw to be Executive Chairperson of Biocon for 5 years starting April 2020

    Kiran Mazumdar Shaw to be Executive Chairperson of Biocon for 5 years starting April 2020

    MD bureau25 Jan 2020 2:14 PM IST
    New Delhi: The Board of Directors of Biocon Limited have approved the appointment of Kiran Mazumdar Shaw as Executive Chairperson of the Company for a...
    Sanofi Completes Acquisition of Synthorx

    Sanofi Completes Acquisition of Synthorx

    Medical Dialogues Bureau25 Jan 2020 12:19 PM IST
    PARIS- Sanofi has announced the successful completion of its acquisition of Synthorx, Inc. for $68 per share in cash. "The acquisition of...
    Alembic Pharma gets final USFDA nod for Bosentan tablets to treat pulmonary arterial hypertension

    Alembic Pharma gets final USFDA nod for Bosentan tablets to treat pulmonary arterial hypertension

    Medical Dialogues Bureau25 Jan 2020 12:11 PM IST
    New Delhi: Alembic Pharmaceuticals (Alembic) on Friday said it has received final nod from US health regulator for Bosentan tablets, used for...
    PrevNext

    Popular Stories

    Lupin gets USFDA EIR for Nagpur Facility

    Lupin gets USFDA EIR for Nagpur Facility

    Top priority on Delivery of Medicines through Speed Post: Minister

    Top priority on Delivery of Medicines through Speed Post: Minister

    India should become self-reliant in medical equipment, devices: Kasturirangan

    India should become self-reliant in medical equipment, devices: Kasturirangan

    NPPA fixes prices of 29 formulations under DPCO, check out details

    NPPA fixes prices of 29 formulations under DPCO, check out details

    AstraZeneca gets USFDA nod for Koselugo for paediatric patients with neurofibromatosis type 1

    AstraZeneca gets USFDA nod for Koselugo for paediatric patients with neurofibromatosis type 1

    KKRs Envision Healthcare hires bank to explore debt restructuring: Report

    KKR's Envision Healthcare hires bank to explore debt restructuring: Report

    Indira IVF to invest Rs 80 crore to expand presence in south India by 2020

    Indira IVF to invest Rs 80 crore to expand presence in south India by 2020

    Shipment of  antimalarial drug to US is likely to start next week: Indian Pharmaceutical Alliance

    Shipment of antimalarial drug to US is likely to start next week: Indian Pharmaceutical Alliance

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok